Daiwa Securities Group
PRAH

Daiwa Securities Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Daiwa Securities Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,780
Closed -$1.12M – 1371
2021
Q2 		$1.12M Sell
6,780
-1,140
-14% -$190K 0.01% 608
2021
Q1 		$1.22M Sell
7,920
-468
-6% -$63.6K 0.01% 558
2020
Q4 		$1.05M Sell
8,388
-1,489
-15% -$167K 0.01% 559
2020
Q3 		$1M Sell
9,877
-54
-0.5% -$5.51K 0.01% 506
2020
Q2 		$62K Hold
9,931
– – ﹤0.01% 903
2020
Q1 		$825K Sell
9,931
-1,279
-11% -$125K 0.01% 529
2019
Q4 		$1.25M Sell
11,210
-813
-7% -$83.6K 0.01% 463
2019
Q3 		$1.19M Buy
12,023
+11,603
+2,763% +$1.15M 0.01% 457
2019
Q2 		$42K Hold
420
– – ﹤0.01% 973
2019
Q1 		$46K Hold
420
– – ﹤0.01% 955
2018
Q4 		$39K Buy
420
+70
+20% +$7.08K ﹤0.01% 942
2018
Q3 		$39K Hold
350
– – ﹤0.01% 974
2018
Q2 		$33K Hold
350
– – ﹤0.01% 993
2018
Q1 		$29K Buy
+350
New +$31.1K ﹤0.01% 979

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Daiwa Securities Group's PRAH Position: Q3 2021 in Review

Daiwa Securities Group sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 6,780 shares — an estimated $1.12M sold.

Daiwa Securities Group first reported a position in PRAH in Q1 2018 and held it in 14 quarters. The position peaked at $1.25M in Q4 2019. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Daiwa Securities Group reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Daiwa Securities Group sold 6,780 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $1.12M.
  • Daiwa Securities Group first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 14 quarters.
  • Daiwa Securities Group's PRA Health Sciences, Inc. position peaked at $1.25M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Daiwa Securities Group's 13F filing for Q3 2021, filed 5 Nov 2021.